Onward Medical Set to Unveil 2025 Milestones and Future Trajectory in Groundbreaking Webcast
- Nishadil
- March 24, 2026
- 0 Comments
- 3 minutes read
- 9 Views
- Save
- Follow Topic
Don't Miss Onward Medical's Full-Year 2025 Financial Results & Business Update Webcast
Onward Medical invites stakeholders to a pivotal webcast unveiling 2025 financial results and key business updates, showcasing their mission to restore movement and independence for individuals with spinal cord injury.
Hey everyone, mark your calendars! Onward Medical, the brilliant minds behind some truly groundbreaking therapies for spinal cord injury, is getting ready to share their full-year 2025 financial results and give us all a good, honest look at where their business is headed. You won't want to miss this vital webcast scheduled for Monday, March 24, 2025.
Set your alarms for 3:00 PM Central European Time (CET) or, for those of us across the pond, 10:00 AM Eastern Daylight Time (EDT). This isn't just going to be a dry numbers presentation; it's a fantastic opportunity to really understand the tangible progress Onward Medical is making in its ambitious mission to restore movement, function, and ultimately, independence for people living with spinal cord injury. It’s pretty inspiring stuff, if you ask me.
During the webcast, you’ll get to hear directly from the folks leading the charge. We’re talking about Dave Marver, the company's Chief Executive Officer, who always brings a clear vision and passion to the table. Then there's Gert-Jan Oskam, the Chief Scientific Officer, ready to delve into the innovative science that drives Onward's cutting-edge work. And, of course, Jeannette T. Maier, the Chief Financial Officer, will expertly walk us through the financial health and strategic investments made throughout 2025. It’s a powerhouse trio, really, offering a comprehensive overview.
For those eager to join, and I sincerely hope many of you are, the webcast will be broadcast live. You can typically find the link on the investor relations section of Onward Medical's official website, or directly through the press release. And if, for whatever reason, you can't make it live – no worries at all! A replay will be made available shortly after the event concludes, so you can catch up at your convenience. Sometimes life just gets in the way, right?
If you prefer to listen in the old-fashioned way, or perhaps you're on the go and need to multitask, dial-in options are readily available too. For those in the Netherlands, you can call +31 20 703 8261. For folks in Belgium, it’s +32 2 789 2529. If you’re joining from the UK, dial +44 330 165 4012, and from the US, it's +1 646 960 0379. Just make sure to use the Conference ID: 4220084 when prompted. Easy peasy!
Just a quick reminder about Onward Medical itself: they are truly a medical technology company with a heart, singularly focused on developing cutting-edge therapies that promise to make a real difference. Their vital work aims to bring back movement and function to individuals impacted by spinal cord injuries, fundamentally improving their quality of life. They’re primarily working with two key technology platforms: the ARC-IM System, which is an implantable neurostimulation system, and the ARC-EX System, their external neurostimulation platform. These sophisticated systems are designed to communicate with the spinal cord, helping to restore lost connections and functionality in remarkable ways.
So, whether you're a seasoned investor, a dedicated medical professional, or simply someone passionate about life-changing innovation and the incredible potential of medical tech, this webcast promises to be incredibly insightful. It's a unique chance to witness firsthand the progress being made in a field that holds so much promise for human well-being. Don't miss out on understanding how Onward Medical is continuing its impactful journey. We'll certainly be tuning in!
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on